Found: 26
Select item for more details and to access through your institution.
Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study.
- Published in:
- Rheumatology International, 2012, v. 32, n. 11, p. 3565, doi. 10.1007/s00296-011-2237-8
- By:
- Publication type:
- Article
Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45178-z
- By:
- Publication type:
- Article
Measurement of CO3-610, a Potential Liver Biomarker Derived from Matrix Metalloproteinase-9 Degradation of Collagen Type III, in a Rat Model of Reversible Carbon-Tetrachloride-Induced Fibrosis.
- Published in:
- Biomarker Insights, 2011, n. 6, p. 49, doi. 10.4137/BMI.S6347
- By:
- Publication type:
- Article
1813-P: Coadministration of a GLP-1/Glucagon Receptor Agonist with an FXR Agonist and ACC Inhibitor Reverses Nonalcoholic Steatohepatitis (NASH) in Diet-Induced and Biopsy-Confirmed Mice.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1813-P
- By:
- Publication type:
- Article
1810-P: Triple Combination Therapy of GLP-1 Receptor Agonist Semaglutide with an FXR Agonist and AC Inhibitor Reverses Nonalcoholic Steatohepatitis (NASH) in Diet-Induced and Biopsy-Confirmed Mice.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1810-P
- By:
- Publication type:
- Article
2020-P: Comparable Disease Progression in GAN and AMLN Diet-Induced Obese Mouse Models of Biopsy-Confirmed Nonalcoholic Steatohepatitis.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2020-P
- By:
- Publication type:
- Article
Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6332, doi. 10.3390/ijms22126332
- By:
- Publication type:
- Article
Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non‐alcoholic steatohepatitis.
- Published in:
- Liver International, 2021, v. 41, n. 8, p. 1853, doi. 10.1111/liv.14888
- By:
- Publication type:
- Article
Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative.
- Published in:
- Liver International, 2020, v. 40, n. 11, p. 2860, doi. 10.1111/liv.14643
- By:
- Publication type:
- Article
Non‐alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion.
- Published in:
- Liver International, 2019, v. 39, n. 11, p. 2094, doi. 10.1111/liv.14205
- By:
- Publication type:
- Article
Enzyme-linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis.
- Published in:
- Hepatology Research, 2012, v. 42, n. 5, p. 482, doi. 10.1111/j.1872-034X.2011.00946.x
- By:
- Publication type:
- Article
Measurement of matrix metalloproteinase 9-mediated Collagen type III degradation fragment as a marker of skin fibrosis.
- Published in:
- BMC Dermatology, 2011, v. 11, n. 1, p. 6, doi. 10.1186/1471-5945-11-6
- By:
- Publication type:
- Article
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-58059-7
- By:
- Publication type:
- Article
Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases.
- Published in:
- Fibrogenesis & Tissue Repair, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1755-1536-6-9
- By:
- Publication type:
- Article
Procollagen type I N-terminal propeptide (PINP) isa marker for fibrogenesis in bile ductligation-induced fibrosis in rats.
- Published in:
- Fibrogenesis & Tissue Repair, 2010, v. 3, p. 5, doi. 10.1186/1755-1536-3-5
- By:
- Publication type:
- Article
MMP Mediated Degradation of Type VI Collagen Is Highly Associated with Liver Fibrosis - Identification and Validation of a Novel Biochemical Marker Assay.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024753
- By:
- Publication type:
- Article
Molecular Characterization of Microvesicular and Macrovesicular Steatosis Shows Widespread Differences in Metabolic Pathways.
- Published in:
- Lipids, 2019, v. 54, n. 1, p. 109, doi. 10.1002/lipd.12121
- By:
- Publication type:
- Article
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model.
- Published in:
- BMC Research Notes, 2012, v. 5, n. 1, p. 1, doi. 10.1186/1756-0500-5-686
- By:
- Publication type:
- Article
Serum markers of liver fibrosis: Combining the BIPED classification and the neo-epitope approach in the development of new biomarkers.
- Published in:
- Disease Markers, 2010, v. 28, n. 1, p. 15, doi. 10.1155/2010/548263
- By:
- Publication type:
- Article
Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C.
- Published in:
- Liver International, 2015, v. 35, n. 2, p. 429, doi. 10.1111/liv.12700
- By:
- Publication type:
- Article
Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis.
- Published in:
- Liver International, 2010, v. 30, n. 9, p. 1293, doi. 10.1111/j.1478-3231.2010.02309.x
- By:
- Publication type:
- Article
Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 5, p. 1167, doi. 10.1111/cts.13235
- By:
- Publication type:
- Article